Drawing for CILIATECH

USPTO serial 79436415

CILIATECH

Reviewed by CopyMark Law Group

Reg. 8258462Status 700Registered
Filing date
Status date
Registration date
May 19, 2026
Examiner
ANKRAH, NAAKWAMA S
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CILIATECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph Sofer

Joseph Sofer IPSILON USA, LLP110 West 40th StreetSUITE 2001New York, NY 10018

Goods and services

ClassDescriptionStatusFirst use
005Biological implants namely, a vital processed human or animal connective tissue, for use in ophthalmology; implants comprising living human or animal tissue for use in ophthalmology; pharmaceutical products for ophthalmological use; Pharmaceutical preparations in the nature of implantable medicines for use in ophthalmology ; Implantable textile material comprising primarily of living tissue to facilitate tissue growth for use in ophthalmology; Medicated eye lotions for medical use; Medicated lubrication eye ointment for medical use.ACTIVE—
010Prostheses for eyes; Prostheses implants consisting primarily of artificial materials and biological materials; Prostheses for surgical treatment for eyes; prostheses for medical use for eyes; Medical devices, instruments and apparatus for the implantation of ophthalmic artificial prostheses; all these goods for use in ophthalmology; ocular implants made of artificial materials; Intraocular implants made of artificial materials; Intraocular prostheses, namely, lenses for surgical implantation; Implants consisting of artificial materials for the use in ophthalmological prostheses surgery; Ophthalmological instruments, namely, surgical instruments for intraocular implant which purpose is to deliver the implant in or close to its final location, in particular forceps, tweezers, injector syringes, injection systems comprising injector syringes or cartridges adapted to contain intraocular implants; therapeutic instruments for ophthalmology; instruments for diagnosis in ophthalmology.ACTIVE—
040Custom manufacture of prostheses.ACTIVE—
041Publication of manuals; publication of documents; provision of non-downloadable electronic publications online; publication of medical texts; publication of scientific articles; editing of medical publications; Writing of articles for journals other than for advertising or publicity; publication of scientific articles relating to medical technology; publication of medical articles in the field of surgery; publication of clinical trial results in the field of surgery.ACTIVE—
042Providing medical and scientific research information in the field of ophthalmology; design of prostheses; development of prostheses; Scientific research in clinical surgery; scientific research for medical purposes; design and development of medical technologies; analysis of human tissues for medical research; Clinical research in the field of ophthalmology; Materials testing; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Scientific research in the nature of conducting clinical trials for others in the field of ophthalmology; basic and clinical research with respect to ophthalmology; design and development of technology with respect to ophthalmology; Medical research and development of new products.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 19, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 26, 2026GPNXNOTIFICATION PROCESSED BY IB—
Mar 25, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 11, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 11, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 4, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 22, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 7, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 7, 2026RFRRREFUSAL PROCESSED BY MPU—
Nov 30, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 25, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 25, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 25, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 25, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 25, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 7, 2025DOCKASSIGNED TO EXAMINER—
Nov 6, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 6, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance